Dr. Jason Coloma serves as the Chief Executive Officer of Maze Therapeutics, guiding the genetic-medicine company as it utilizes its proprietary functional genomics platform to translate genetic insights into novel precision therapeutics. Under his leadership, the enterprise focuses on uncovering complex drivers of disease, advancing novel small molecule pipelines, and expanding strategic collaborations to address severe conditions in areas such as cardiology and renal medicine.